INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$2.7M

$2,711,664

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
SYRE M Spyre Therapeutics, Inc. Burrows Scott L • CFO Other 2026-03-03 $36,250 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Burrows Scott L CFO Other	2026-03-03	$36,250	M	Form 4
SYRE S Spyre Therapeutics, Inc. Burrows Scott L • CFO 10b5-1 Sell 2026-03-03 $101,620x2 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Burrows Scott L CFO 10b5-1 Sell	2026-03-03	$101,620x2	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2026-03-02 $632,866x2 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2026-03-02	$632,866x2	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2026-02-02 $492,045x2 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2026-02-02	$492,045x2	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2025-12-01 $435,356x2 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2025-12-01	$435,356x2	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2025-11-03 $1,049,778Largex2 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2025-11-03	$1,049,778Largex2	S	Form 4